SCHEMBL22927344

SCHEMBL22927344

c1ccc(-c2ccc(-n3c4ccccc4c4c5cccc6c5c(cc43)-c3ccccc3-c3ccccc3-6)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.43
▸ ATM Q13315 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ HDAC4 P56524 1/20 0.37
▸ HKDC1 Q2TB90 1/20 0.36
▸ KMT2A Q03164 3/20 0.35
▸ IL1R1 P14778 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ PDE6D O43924 1/20 0.34
▸ CRHBP P24387 1/20 0.33
▸ CRHR2 Q13324 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12495628 0.93 L3MBTL1 (0.46) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL21302918 0.92 L3MBTL1 (0.37) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL22927343 0.91 L3MBTL1 (0.36) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL12495775 0.91 L3MBTL1 (0.53) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL22927313 0.91 L3MBTL1 (0.38) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL12492842 0.90 L3MBTL1 (0.39) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL17341475 0.90 L3MBTL1 (0.39) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL12494138 0.90 L3MBTL1 (0.39) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL19918659 0.90 L3MBTL1 (0.44) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL12496370 0.89 L3MBTL1 (0.36) L3MBTL1ATMKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024466-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2021-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024466-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ICOSLG, SOD1, OR10J3 L3MBTL1 152/4885ATM 2161/4885KDM4E 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback